-
Molecular Diagnostics Company Acquired in $1.8B Deal
GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion.
-
Biotech Manufacturer Gains $525M in New Funds
A company providing specialized lab and manufacturing services for cell and gene therapy developers is raising $525 million in its third venture funding round.
-
Infographic – Steady Growth for mRNA Trials
The pandemic has demonstrated messenger RNA’s recognized potential for vaccines and treatments that induce an immune response.
-
Smart Walking System Wins Multiple Sclerosis Challenge
A company developing systems to assist with walking is the winner of a competition for innovations to help people with multiple sclerosis.
-
New Covid-19 mRNA Vaccine Trial Begins
A clinical trial is underway testing a new Covid-19 vaccine based on messenger RNA, developed by biotech company Translate Bio and drug maker Sanofi.
-
Finding Your Business Opportunity Overseas
Looking overseas is one of the best opportunities you might have to take a business to where a market is ready and waiting for it.
-
Trial Tests Microbiome Effect on Covid-19 Vaccines
A clinical trial is underway assessing the impact of gut microbes on immune responses generated by vaccines protecting against Covid-19 disease.
-
In-Body Gene Editing Tested as Sickle Cell Treatment
Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease.
-
CEPI Funding SARS-CoV-2 Variant Vaccines
CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil.
-
Trial Shows Electronic Treatments Slow Brain Decline
Results from a clinical trial show treatments of electronic audio and visual impulses slow cognitive and functional decline in people with Alzheimer’s disease.